Biological properties and gene expression associated with metastatic potential of human osteosarcoma

Clinical and Experimental Metastasis

Volumn 20, Issue 7, 2003, Pages 665-674

  Nakano, Tetsuhiro ^a,b   Tani, Masachika ^a   Ishibashi, Yasunori ^a   Kimura, Kenji ^a   Park, Yong Bum ^a   Imaizumi, Natsuko ^a   Tsuda, Hiroyuki ^a   Aoyagi, Kazuhiko ^a   Sasaki, Hiroki ^a   Ohwada, Susumu ^b   Yokota, Jun ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

cDNA microarray; Human osteosarcoma cell line; Invasion; Lung metastasis; Motility

Indexed keywords

COMPLEMENTARY DNA;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AXL GENE; CANCER GENETICS; CANCER GROWTH; CANCER INVASION; CARCINOGENICITY; CELL ADHESION; CELL INVASION; CELL ISOLATION; CELL MOTILITY; COLL7A1 GENE; CONTROLLED STUDY; CORRELATION ANALYSIS; DILUTION; DISEASE ASSOCIATION; DNA MICROARRAY; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GROWTH RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INJECTION; LUNG METASTASIS; LUNG NODULE; METASTASIS POTENTIAL; MKK6 GENE; MOUSE; NONHUMAN; OSTEOSARCOMA; TAIL; TFGA GENE; VEIN; WNT5A GENE;

ANIMALS; BONE NEOPLASMS; CELL ADHESION; CELL MOVEMENT; FEMALE; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOSARCOMA; TUMOR CELLS, CULTURED;

EID: 0345304776     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027355610603     Document Type: Article

References (51)

1. Tsuchiya H, Kanazawa Y, Abdel-Wanis ME et al. Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: The Japanese Musculoskeletal Oncology Group study. J Clin Oncol 2002; 20(16): 3470-7.
2. Yokota J. Tumor progression and metastasis. Carcinogenesis 2000; 21(3): 497-503.
3. Ishiguro T, Nakajima M, Naito M et al. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. Cancer Res 1996; 56(4): 875-9.
4. Clark EA, Golub TR, Lander ES et al. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000; 406(6795): 532-5.
5. Hashimoto Y, Shindo-Okada N, Tani M et al. Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display. Cancer Res 1996; 56(22): 5266-71.
6. Bittner M, Meltzer P, Chen Y et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000; 406(6795): 536-40.
7. Kimura K, Nakano T, Park YB et al. Establishment of human osteosarcoma cell lines with high metastatic potential to lungs and their utilities for therapeutic studies on metastatic osteosarcoma. Clin Exp Metastasis 2002; 19(6): 477-85.
8. Mori S, Ueda T, Kuratsu S et al. Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma. Int J Cancer 1995; 61(1): 148-52.
9. Honoki K, Tsutsumi M, Miyauchi Y et al. Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-transplantable osteosarcomas. Cancer Res 1993; 53(20): 5038-42.
10. Barroga EF, Kadosawa T, Okumura M et al. Establishment and characterization of the growth and pulmonary metastasis of a highly lung metastasizing cell line from canine osteosarcoma in nude mice. J Vet Med Sci 1999; 61(4): 361-7.
11. Khanna C, Khan J, Nguyen P et al. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 2001; 61(9): 3750-9.
12. Worth LL, Lafleur EA, Jia SF et al. Fas expression inversely correlates with metastatic potential in osteosarcoma cells. Oncol Rep 2002; 9(4): 823-7.
13. Berlin O, Samid D, Donthineni-Rao R et al. Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. Cancer Res 1993; 53(20): 4890-5.
14. Meyer WH, Houghton JA, Houghton PJ et al. Development and characterization of pediatric osteosarcoma xenografts. Cancer Res 1990; 50(9): 2781-5.
15. Grenman R, Burk D, Virolainen E et al. Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines using limiting dilution. Int J Cancer 1989; 44(1): 131-6.
16. Vihinen P, Riikonen T, Laine A et al. Integrin α2β1 in tumorigenic human osteosarcoma cell lines regulates cell adhesion, migration, and invasion by interaction with type I collagen. Cell Growth Differ 1996; 7(4): 439-47.
17. Raz A, Hanna N, Fidler IJ. In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes. J Natl Cancer Inst 1981; 66(1): 183-9.
18. Nicolson GL, Custead SE. Tumor metastasis is not due to adaptation of cells to a new organ environment. Science 1982; 215(4529): 176-8.
19. Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer 1997; 80(Suppl 8): 1529-37.
20. Yoshida BA, Sokoloff MM, Welch DR et al. Metastasis-suppressor genes: a review and perspective on an emerging field. J Natl Cancer Inst 2000; 92(21): 1717-30.
21. Izumi Y, Taniuchi Y, Tsuji T et al. Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells. Exp Cell Res 1995; 216(1): 215-21.
22. Al-Mehdi AB, Tozawa K, Fisher AB et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: A new model for metastasis. Nat Med 2000; 6(1): 100-2.
23. Ito S, Nakanishi H, Ikehara Y et al. Real-time observation of micrometastasis formation in the living mouse liver using a green fluorescent protein gene-tagged rat tongue carcinoma cell line. Int J Cancer 2001; 93(2): 212-7.
24. Miller CW, Aslo A, Won A et al. Alterations of the p53, Rb and MDM2 genes in osteosarcoma. J Cancer Res Clin Oncol 1996; 122(9): 559-65.
25. Nielsen GP, Burns KL, Rosenberg AE et al. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations. Am J Pathol 1998; 153(1): 159-63.
26. Yokota J, Sugimura T. Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J 1993; 7(10): 920-5.
27. Park YB, Park MJ, Kimura K et al. Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines. Cancer Genet Cytogenet 2002; 133(2): 105-11.
28. Radinsky R, Fidler IJ, Price JE et al. Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild type p53. Oncogene 1994; 9(7): 1877-83.
29. Stanelle J, Stiewe T, Theseling CC et al. Gene expression changes in response to E2F1 activation. Nucleic Acids Res 2002; 30(8): 1859-67.
30. Jackson P, Puisieux A. Is the KAI1 metastasis suppressor gene a cellular target of p53? A review of current evidence. Biochem Biophys Res Comm 2000; 278(3): 499-502.
31. Mukhopadhyay D, Tsiokas L, Sukhatme VP. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 1995; 55(24): 6161-5.
32. Kawai A, Ozaki T, Ikeda S et al. Two distinct cell lines derived from a human osteosarcoma. J Cancer Res Clin Oncol 1989; 115(6): 531-6.
33. Ladanyi M, Cha C, Lewis R et al. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 1993; 53(1): 16-8.
34. O'Bryan JP, Frye RA, Cogswell PC et al. Axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 1991; 11(10): 5016-31.
35. Nakano T, Ishimoto Y, Kishino J et al. Cell adhesion to phosphatidylserine mediated by a product of growth arrest-specific gene 6. J Biol Chem 1997; 272(47): 29411-4.
36. McCloskey P, Fridell YW, Attar E et al. GAS6 mediates adhesion of cells expressing the receptor tyrosine kinase Axl. J Biol Chem 1997; 272(37): 23285-91.
37. Wimmel A, Glitz D, Kraus A et al. Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion. Eur J Cancer 2001; 37(17): 2264-74.
38. Craven RJ, Xu LH, Weiner TM et al. Receptor tyrosine kinases expressed in metastatic colon cancer. Int J Cancer 1995; 60(6): 791-7.
39. Wu CW, Li AF, Chi CW et al. Clinical significance of AXL kinase family in gastric cancer. Anticancer Res 2002; 22(2B): 1071-8.
40. Quong RY, Bickford ST, Ing YL et al. Protein kinases in normal and transformed melanocytes. Melanoma Res 1994; 4(5): 313-9.
41. Weiner TM, Liu ET, Craven RJ et al. Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors. Ann Surg Oncol 1994; 1(1): 18-27.
42. Weeraratna AT, Jiang Y, Hostetter G et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002; 1(3): 279-88.
43. Finzi E, Fleming T, Segatto O et al. The human transforming growth factor type alpha coding sequence is not a direct-acting oncogene when overexpressed in NIH 3T3 cells. Proc Natl Acad Sci USA 1987; 84(11): 3733-7.
44. Khazaie K, Schirrmacher V, Lichtner RB. EGF receptor in neoplasia and metastasis. Cancer Metast Rev 1993; 12(3-4): 255-74.
45. Kawanami O, Ferrans VJ, Roberts WC et al. Anchoring fibrils. A new connective tissue structure in fibrotic lung disease. Am J Pathol 1978; 92(2): 389-410.
46. Sakai LY, Keene DR, Morris NP et al. Type VII collagen is a major structural component of anchoring fibrils. J Cell Biol 1986; 103(4): 1577-86.
47. Visser R, Arends JW, Leigh IM et al. Patterns and composition of basement membranes in colon adenomas and adenocarcinomas. J Pathol 1993; 170(3): 285-90.
48. Raingeaud J, Whitmarsh AJ, Barrett T et al. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 1996; 16(3): 1247-55.
49. Li W, Nadelman C, Henry G et al. The p38-MAPK/SAPK pathway is required for human keratinocyte migration on dermal collagen. J Invest Dermatol 2001; 117(6): 1601-11.
50. Westermarck J, Li SP, Kallunki T et al. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression. Mol Cell Biol 2001; 21(7): 2373-83.
51. Montero L, Nagamine Y. Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion. Cancer Res 1999; 59(20): 5286-93.